威权主义的风险:日本的纤维素原传播的型肝炎
1Department of Planning, Information and Management, University of Tokyo Hospital, Tokyo, Japan. yasunagah-jyo@h.u-tokyo.ac.jp
Lancet (London, England)
|December 18, 2007
概括
由于政策变化延迟,日本的纤维素缩剂使用导致1万例C型肝炎感染. 这强调了科学家和政策制定者需要根据不断变化的科学证据不断更新实践.
科学领域:
- 医学 医学 医学 医学 医学
- 公共卫生 公共卫生
- 医学史 医学史 医学史
背景情况:
- 纤维素缩剂在1988年之前在日本广泛用于产科出血,尽管美国在1977年因肝炎风险而撤销许可证.
- 日本的学术产科文本在1997年也继续推纤维素缩剂.
研究的目的:
- 分析延迟政策变化对日本纤维素缩剂使用的影响.
- 检查专制主义阻碍有效调整公共卫生政策的作用.
主要方法:
- 在日本和美国使用纤维素缩物和许可证的历史审查.
- 对有关肝炎传播的科学证据的公共卫生政策反应的分析.
主要成果:
- 据估计,日本约有1万例型肝炎感染病例与使用纤维素缩剂有关.
- 医疗界内的威权结构阻碍了及时的政策改革.
结论:
- 在日本,持续使用纤维素缩物导致了严重的C型肝炎传播.
- 公共卫生政策的持续调整至关重要,以与科学进步保持一致.
相关概念视频
Factors Affecting the Risk of Infection
The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...
Hazard Ratio
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial evaluating a...
For example, in a clinical trial evaluating a...
Hepatitis
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Amebiasis
Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...
Viral Hepatitis I: Introduction
Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Cirrhosis II: Pathophysiology
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...


